SEOUL, South Korea, June 17, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) and SD BIOSENSOR (CEO Hyo-Keun, Lee) entered into a Supply Agreement, where Yuyu Pharma will export ...
SINGAPORE - The Health Sciences Authority (HSA) said SD Biosensor and Flowflex antigen rapid test (ART) kits involved in a recall in the United States are safe and fit for use in Singapore. The ...
SD Biosensor, a Korean developer of COVID-19 test kits, said Friday it has signed a deal to buy an Italian medical device distributor for 61.9 billion won ($49.8 million) in an effort to tap deeper ...
The launch took place at the I2DM2025 Summit, hosted at Khalifa University in Abu Dhabi. The kit is designed for scientists exploring graphene field-effect transistors (GFETs) in biosensing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results